{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:03:35Z","timestamp":1792602215603,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["1H79SM080388-01"],"award-info":[{"award-number":["1H79SM080388-01"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005386","name":"American Psychiatric Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.josat.2023.209216","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T20:11:15Z","timestamp":1700251875000},"page":"209216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Access challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets"],"prefix":"10.1016","volume":"157","author":[{"given":"Michael","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia S.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Ting","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwole","family":"Jegede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniket","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.josat.2023.209216_bb0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13011-021-00395-6","article-title":"The impact of COVID-19 on healthcare delivery for people who use opioids: A scoping review","volume":"16","author":"Alexander","year":"2021","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"1","key":"10.1016\/j.josat.2023.209216_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227966","article-title":"Socioeconomic risk factors for fatal opioid overdoses in the United States: Findings from the Mortality Disparities in American Communities Study (MDAC)","volume":"15","author":"Altekruse","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.josat.2023.209216_bb0015","author":"American Society of Addiction Medicine"},{"issue":"10","key":"10.1016\/j.josat.2023.209216_bb0020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1542\/hpeds.2016-0024","article-title":"A qualitative study of family experience with hospitalization for neonatal abstinence syndrome","volume":"6","author":"Atwood","year":"2016","journal-title":"Hospital Pediatrics"},{"issue":"1","key":"10.1016\/j.josat.2023.209216_bb0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jadohealth.2022.08.026","article-title":"Ambivalence and stigma beliefs about medication treatment among young adults with opioid use disorder: A qualitative exploration of young adults\u2019 perspectives","volume":"72","author":"Bagley","year":"2023","journal-title":"The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine"},{"issue":"6","key":"10.1016\/j.josat.2023.209216_bb0030","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/15332985.2021.1930329","article-title":"A collaborative culturally-centered and community-driven faith-based opioid recovery initiative: The Imani Breakthrough project","volume":"19","author":"Bellamy","year":"2021","journal-title":"Social Work in Mental Health"},{"key":"10.1016\/j.josat.2023.209216_bb0035","series-title":"Qualitative research methods for social sciences","author":"Berg","year":"2001"},{"issue":"9","key":"10.1016\/j.josat.2023.209216_bb0040","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: A national clinical practice guideline","volume":"190","author":"Bruneau","year":"2018","journal-title":"CMAJ: Canadian Medical Association Journal"},{"key":"10.1016\/j.josat.2023.209216_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108779","article-title":"Accessibility of substance use treatment: A qualitative study from the non-service users\u2019 perspective","volume":"141","author":"Caris","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209216_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108719","article-title":"Racial\/ethnic disparities in the availability of hospital based opioid use disorder treatment","volume":"138","author":"Chang","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209216_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.drugalcdep.2018.04.012","article-title":"Exploring opioid use disorder, its impact, and treatment among individuals experiencing homelessness as part of a family","volume":"188","author":"Chatterjee","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2023.209216_bb0060","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/08897077.2021.2010251","article-title":"\u201cI wanted something that was more flexible\u201d: A qualitative study of patient preferences on choosing buprenorphine over methadone in a large, safety-net hospital opioid treatment program","volume":"43","author":"Checkley","year":"2022","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2023.209216_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/SAR.S304566","article-title":"The impact of stigma on people with opioid use disorder, opioid treatment, and policy","volume":"13","author":"Cheetham","year":"2022","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"1","key":"10.1016\/j.josat.2023.209216_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/jamia\/ocaa217","article-title":"Telemedicine and healthcare disparities: A cohort study in a large healthcare system in New York City during COVID-19","volume":"28","author":"Chunara","year":"2021","journal-title":"Journal of the American Medical Informatics Association"},{"key":"10.1016\/j.josat.2023.209216_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108283","article-title":"Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island","volume":"124","author":"Clark","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209216_bb0080","series-title":"Techniques and procedures for developing grounded theory","article-title":"Basics of qualitative research","author":"Corbin","year":"2008"},{"key":"10.1016\/j.josat.2023.209216_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108870","article-title":"Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study","volume":"142","author":"David","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209216_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106845","article-title":"Growing racial\/ethnic disparities in overdose mortality before and during the COVID-19 pandemic in California","volume":"153","author":"Friedman","year":"2021","journal-title":"Preventive Medicine"},{"issue":"4","key":"10.1016\/j.josat.2023.209216_bb0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamapsychiatry.2022.0004","article-title":"Evaluation of increases in drug overdose mortality rates in the US by race and ethnicity before and during the COVID-19 pandemic","volume":"79","author":"Friedman","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2023.209216_bb0100","series-title":"The discovery of grounded theory: Strategies for qualitative research","author":"Glaser","year":"1967"},{"issue":"3","key":"10.1016\/j.josat.2023.209216_bb0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1521-0391.2012.12004.x","article-title":"Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system","volume":"22","author":"Gryczynski","year":"2013","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.josat.2023.209216_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108551","article-title":"Experiences of racial discrimination in the medical setting and associations with medical mistrust and expectations of care among black patients seeking addiction treatment","volume":"133","author":"Hall","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209216_bb0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2016.03.028","article-title":"Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City","volume":"164","author":"Hansen","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2023.209216_bb0120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10826084.2017.1385633","article-title":"At the expense of a life: Race, class, and the meaning of bupre-norphine in pharmaceuticalized \u201ccare\u201d","volume":"53","author":"Hatcher","year":"2018","journal-title":"Substance Use & Misuse"},{"issue":"1","key":"10.1016\/j.josat.2023.209216_bb0125","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.44955","article-title":"Perspectives about emergency department care encounters among adults with opioid use disorder","volume":"5","author":"Hawk","year":"2022","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2023.209216_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108464","article-title":"Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees","volume":"131","author":"Hoffman","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209216_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108927","article-title":"Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use","volume":"227","author":"Hollander","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2023.209216_bb0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/00981389.2015.1078427","article-title":"Experiences of opioid-dependent women in their prenatal and postpartum care: Implications for social workers in health care","volume":"55","author":"Howard","year":"2016","journal-title":"Social Work in Health Care"},{"issue":"12","key":"10.1016\/j.josat.2023.209216_bb0145","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1542\/hpeds.2018-0116","article-title":"The joys and frustrations of breastfeeding and rooming-in among mothers with opioid use disorder: A qualitative study","volume":"8","author":"Howard","year":"2018","journal-title":"Hospital Pediatrics"},{"issue":"10","key":"10.1016\/j.josat.2023.209216_bb0150","doi-asserted-by":"crossref","DOI":"10.2196\/21814","article-title":"Digital phenotyping to enhance substance use treatment during the COVID-19 pandemic","volume":"7","author":"Hsu","year":"2020","journal-title":"JMIR Mental Health"},{"issue":"7","key":"10.1016\/j.josat.2023.209216_bb0155","doi-asserted-by":"crossref","DOI":"10.2196\/38684","article-title":"Smartphone ownership, smartphone utilization, and interest in using mental health apps to address substance use disorders: Literature review and cross-sectional survey study across two sites","volume":"6","author":"Hsu","year":"2022","journal-title":"JMIR Formative Research"},{"issue":"29","key":"10.1016\/j.josat.2023.209216_bb0160","doi-asserted-by":"crossref","first-page":"940","DOI":"10.15585\/mmwr.mm7129e2","article-title":"Vital signs: Drug overdose deaths, by selected sociodemographic and social determinants of health characteristics \u2014 25 states and the District of Columbia, 2019\u20132020","volume":"71","author":"Kariisa","year":"2022","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"9","key":"10.1016\/j.josat.2023.209216_bb0165","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","article-title":"Buprenorphine treatment divide by race\/ethnicity and payment","volume":"76","author":"Lagisetty","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.josat.2023.209216_bb0170","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2105\/AJPH.2021.306431","article-title":"Disparities in opioid overdose death trends by race\/ethnicity, 2018\u20132019, from the HEALing Communities study","volume":"111","author":"Larochelle","year":"2021","journal-title":"American Journal of Public Health"},{"issue":"14","key":"10.1016\/j.josat.2023.209216_bb0175","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1080\/10826084.2021.1975749","article-title":"Intervention stigma toward medications for opioid use disorder: A systematic review","volume":"56","author":"Madden","year":"2021","journal-title":"Substance Use & Misuse"},{"issue":"1","key":"10.1016\/j.josat.2023.209216_bb0180","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.42982","article-title":"Disparities by sex and race and ethnicity in death rates due to opioid overdose among adults 55 years or older, 1999 to 2019","volume":"5","author":"Mason","year":"2022","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.josat.2023.209216_bb0185","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/15332640.2018.1548323","article-title":"Anti-racism and substance use treatment: Addiction does not discriminate, but do we?","volume":"19","author":"Matsuzaka","year":"2020","journal-title":"Journal of Ethnicity in Substance Abuse"},{"key":"10.1016\/j.josat.2023.209216_bb0190","series-title":"Qualitative data analysis: An expanded sourcebook","first-page":"xiv","volume":"Vol. 338","author":"Miles","year":"1994"},{"key":"10.1016\/j.josat.2023.209216_bb0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12954-020-00399-8","article-title":"\u201cThey look at us like junkies\u201d: Influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City","volume":"17","author":"Muncan","year":"2020","journal-title":"Harm Reduction Journal"},{"issue":"6","key":"10.1016\/j.josat.2023.209216_bb0200","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.14765","article-title":"Racial and ethnic disparities in buprenorphine and extended-release naltrexone filled prescriptions during the COVID-19 pandemic","volume":"5","author":"Nguyen","year":"2022","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.josat.2023.209216_bb0205","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/ADM.0000000000000491","article-title":"\u201cI didn\u2019t want to be on Suboxone at first\u2026\u201d \u2013 Ambivalence in perinatal substance use treatment","volume":"13","author":"Ostrach","year":"2019","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.josat.2023.209216_bb0210","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s40615-021-01095-4","article-title":"Treatment outcomes among Black adults receiving medication for opioid use disorder","volume":"9","author":"Parlier-Ahmad","year":"2022","journal-title":"Journal of Racial and Ethnic Health Disparities"},{"issue":"2","key":"10.1016\/j.josat.2023.209216_bb0215","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00005650-198102000-00001","article-title":"The concept of access: Definition and relationship to consumer satisfaction","volume":"19","author":"Penchansky","year":"1981","journal-title":"Medical Care"},{"issue":"5","key":"10.1016\/j.josat.2023.209216_bb0220","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1533-2500.2010.00378.x","article-title":"Current knowledge of buprenorphine and its unique pharmacological profile","volume":"10","author":"Pergolizzi","year":"2010","journal-title":"Pain Practice: The Official Journal of World Institute of Pain"},{"issue":"1","key":"10.1016\/j.josat.2023.209216_bb0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drugpo.2008.07.004","article-title":"Why don\u2019t out-of-treatment individuals enter methadone treatment programs?","volume":"21","author":"Peterson","year":"2010","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2023.209216_bb0230","series-title":"Life and loss on Methadone Mile","author":"Ramos","year":"2016"},{"issue":"1","key":"10.1016\/j.josat.2023.209216_bb0235","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13722-020-0177-x","article-title":"Case report: Successful induction of buprenorphine\/naloxone using a microdosing schedule and assertive outreach","volume":"15","author":"Rozylo","year":"2020","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"10.1016\/j.josat.2023.209216_bb0240","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1377\/hlthaff.2011.0983","article-title":"Blacks and Hispanics are less likely than whites to complete addiction treatment, largely due to socioeconomic factors","volume":"32","author":"Saloner","year":"2013","journal-title":"Health Affairs (Project Hope)"},{"issue":"5","key":"10.1016\/j.josat.2023.209216_bb0245","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5734","article-title":"Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts","volume":"3","author":"Schiff","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2023.209216_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108765","article-title":"\u201cYou have to take this medication, but then you get punished for taking it:\u201d lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period","volume":"139","author":"Schiff","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209216_bb0255","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drugpo.2019.09.003","article-title":"\u201cEverything is not right anymore\u201d: Buprenorphine experiences in an era of illicit fentanyl","volume":"74","author":"Silverstein","year":"2019","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2023.209216_bb1000","series-title":"The Physical Evaluation of Patients Who Will Be Treated With Buprenorphine at Opioid Treatment Programs","year":"2023"},{"issue":"5","key":"10.1016\/j.josat.2023.209216_bb0260","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/02791072.2014.921743","article-title":"Patient perspectives on buprenorphine\/naloxone: A qualitative study of retention during the Starting Treatment with Agonist Replacement Therapies (START) study","volume":"46","author":"Teruya","year":"2014","journal-title":"Journal of Psychoactive Drugs"},{"issue":"20","key":"10.1016\/j.josat.2023.209216_bb0265","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/jama.2019.16932","article-title":"Life expectancy and mortality rates in the United States, 1959\u20132017","volume":"322","author":"Woolf","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2023.209216_bb0270","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.genhosppsych.2020.09.004","article-title":"Disparities in outpatient visits for mental health and\/or substance use disorders during the COVID surge and partial reopening in Massachusetts","volume":"67","author":"Yang","year":"2020","journal-title":"General Hospital Psychiatry"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:40:32Z","timestamp":1762652432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923002679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":55,"alternative-id":["S2949875923002679"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209216","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Access challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209216"}}